These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 33083917)

  • 1. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
    Monreal E; Sainz de la Maza S; Natera-Villalba E; Beltrán-Corbellini Á; Rodríguez-Jorge F; Fernández-Velasco JI; Walo-Delgado P; Muriel A; Zamora J; Alonso-Canovas A; Fortún J; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):761-769. PubMed ID: 33083917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
    Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
    Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.
    Papamanoli A; Yoo J; Grewal P; Predun W; Hotelling J; Jacob R; Mojahedi A; Skopicki HA; Mansour M; Marcos LA; Kalogeropoulos AP
    Eur J Clin Invest; 2021 Feb; 51(2):e13458. PubMed ID: 33219551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
    Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
    Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids in critical COVID-19: Are all corticosteroids equal?
    Du Plessis EM; Lalla U; Allwood BW; Louw EH; Nortje A; Parker A; Taljaard JJ; Ayele BT; Nyasulu PS; Koegelenberg CFN
    S Afr Med J; 2021 Apr; 111(6):550-553. PubMed ID: 34382564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of corticosteroids on chest high-resolution computed tomography features of COVID-19 pneumonia.
    Calabrese C; Pafundi PC; Mollica M; Annunziata A; Imitazione P; Lanza M; Polistina G; Flora M; Guarino S; Palumbo C; Fiorentino G
    Ther Adv Respir Dis; 2021; 15():17534666211042533. PubMed ID: 34565246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
    Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
    J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
    Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
    J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain.
    Ramírez P; Gordón M; Martín-Cerezuela M; Villarreal E; Sancho E; Padrós M; Frasquet J; Leyva G; Molina I; Barrios M; Gimeno S; Castellanos Á
    Med Intensiva (Engl Ed); 2021; 45(1):27-34. PubMed ID: 32919796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
    Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R;
    JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
    Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
    Park E; You J
    J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum Ferritin Levels and Methylprednisolone Treatment With Outcomes in Nonintubated Patients With Severe COVID-19 Pneumonia.
    Papamanoli A; Kalogeropoulos AP; Hotelling J; Yoo J; Grewal P; Predun W; Jacob RP; Cao K; Marcos LA; Skopicki HA
    JAMA Netw Open; 2021 Oct; 4(10):e2127172. PubMed ID: 34605919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone use in children with severe pneumonia caused by severe acute respiratory syndrome coronavirus 2.
    Ozsurekci Y; Aykac K; Demir OO; Ilbay S; Kesici S; Karakaya J; Cengiz AB
    Pediatr Int; 2023; 65(1):e15603. PubMed ID: 37615374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study.
    Lopinto J; Arrestier R; Peiffer B; Gaillet A; Voiriot G; Urbina T; Luyt CE; Bellaïche R; Pham T; Ait-Hamou Z; Roux D; Clere-Jehl R; Azoulay E; Gaudry S; Mayaux J; Mekontso Dessap A; Canoui-Poitrine F; de Prost N
    Crit Care Med; 2023 Oct; 51(10):1306-1317. PubMed ID: 37199534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
    Monreal E; Maza S S; Gullón P; Natera-Villalba E; Chico-García JL; Beltrán-Corbellini Á; Martínez-Sanz J; García-Barragán N; Buisán J; Toledano R; Alonso-Canovas A; Pérez-Torre P; Matute-Lozano MC; López-Sendón JL; García-Ribas G; Corral Í; Fortún J; Montero-Errasquín B; Manzano L; Máiz-Carro L; Costa-Frossard L; Masjuan J;
    J Med Virol; 2021 Apr; 93(4):2243-2251. PubMed ID: 33165922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
    Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
    [No Abstract]   [Full Text] [Related]  

  • 19. Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients?
    Kumar G; Patel D; Hererra M; Jefferies D; Sakhuja A; Meersman M; Dalton D; Nanchal R; Guddati AK
    J Med Virol; 2022 Jan; 94(1):372-379. PubMed ID: 34559436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.